Nicolini, F. E., Etienne, G., Dubruille, V., Roy, L., Huguet, F., Legros, L., Giraudier, S., Coiteux, V., Guerci-Bresler, A., Lenain, P., Cony-Makhoul, P., Gardembas, M., Hermet, E., Rousselot, P., Amé, S., Gagnieu, M., Pivot, C., Hayette, S., Maguer-Satta, V., Etienne, M., Dulucq, S., Rea, D., & Mahon, F. (2015). nilotinib and peginterferon alfa-2a for newly diagnosed chronic-phase chronic myeloid leukaemia (NiloPeg): a multicentre, non-randomised, open-label phase 2 study. Lancet, 2(1), e37–e46. http://access.bl.uk/ark:/81055/vdc_100066540074.0x000008